Division of Dermatology, Beijing University of Chinese Medicine Third Affiliated Hospital, Beijing, China.
Division of Urology, Dongfang Hospital Beijing University of Chinese Medicine, Beijing, China.
Ann Palliat Med. 2021 Mar;10(3):2736-2746. doi: 10.21037/apm-20-1440. Epub 2021 Jan 26.
Laser therapy has recently been proposed as a novel treatment for stress urinary incontinence (SUI) due to offering several advantages. This study aimed to evaluate the safety and efficacy of laser treatment of SUI by a meta-analysis.
The systematic review registration number is INPLASY202080001. A comprehensive search to identify relevant studies was conducted using the PubMed, Embase, Cochrane Library, CNKI, VIP and Wanfang databases with a cutoff date of 1 November, 2020. Outcome measures were extracted based on subjective and objective indexes, including International Consultation on Incontinence Questionnaire-Short Form (ICIQ-UI-SF), Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire (PISQ-12), and objective measurements "1-hour pad test" (1-hour test under standardized conditions). Score changes before and after treatment were evaluated through meta-analysis. Subgroup analysis was performed according to geographic region, type of urinary incontinence (UI), severity of UI, age, and body mass index (BMI).
Sixteen published clinical research studies, involving 899 patients with SUI, were included in this study. After laser treatment, the change in the ICIQ-SF score at 1, 2, and 6 months was -5.49 (95% CI: -6.74--4.24; I2=91%, P<0.01), -4.97 (95% CI: -6.24--3.71), and -5.48 (95% CI: -6.15--4.81), respectively. The improvement in 1-hour pad weight test results at 1, 3, and 12 months post treatment was -5.59 (95% CI: -6.93--4.25), -4.96 (95% CI: -6.73--3.20), and -5.82 (95% CI: -6.77--4.87), respectively. The PISQ-12 score increased by 5.39 (95% CI: 1.20-9.58) following treatment. Subgroup analysis identified the type and severity of UI as the potential source of heterogeneity. Adverse effects were reported in 6 of the 16 trials and affected only a small number of patients. Most adverse events were mild or moderate and required no medical intervention or resolved in a few days.
Vaginal laser therapy appears to be a safe, effective, and minimally invasive treatment option for SUI that can be well tolerated by patients.
激光治疗由于具有多种优势,最近被提议作为治疗压力性尿失禁(SUI)的一种新方法。本研究旨在通过荟萃分析评估激光治疗 SUI 的安全性和疗效。
系统评价注册编号为 INPLASY202080001。使用 PubMed、Embase、Cochrane 图书馆、CNKI、VIP 和万方数据库进行全面搜索,以确定截至 2020 年 11 月 1 日的相关研究。根据主观和客观指标提取结局测量值,包括国际尿失禁咨询问卷简表(ICIQ-UI-SF)、盆腔器官脱垂/尿失禁性功能问卷(PISQ-12)和客观测量“1 小时垫试验”(标准化条件下的 1 小时试验)。通过荟萃分析评估治疗前后的评分变化。根据地理区域、尿失禁类型(UI)、UI 严重程度、年龄和体重指数(BMI)进行亚组分析。
本研究纳入了 16 项已发表的临床研究,共涉及 899 例 SUI 患者。激光治疗后,1、2 和 6 个月时 ICIQ-SF 评分的变化分别为-5.49(95%CI:-6.74--4.24;I²=91%,P<0.01)、-4.97(95%CI:-6.24--3.71)和-5.48(95%CI:-6.15--4.81)。治疗后 1、3 和 12 个月时 1 小时垫重试验结果的改善分别为-5.59(95%CI:-6.93--4.25)、-4.96(95%CI:-6.73--3.20)和-5.82(95%CI:-6.77--4.87)。治疗后 PISQ-12 评分增加了 5.39(95%CI:1.20-9.58)。亚组分析确定了尿失禁的类型和严重程度是异质性的潜在来源。16 项试验中的 6 项报告了不良反应,仅影响少数患者。大多数不良事件为轻度或中度,无需医疗干预或在数天内自行缓解。
阴道激光治疗似乎是一种安全、有效、微创的 SUI 治疗选择,患者耐受性良好。